Stock Update (NASDAQ:AMGN): Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference

[PR Newswire] – THOUSAND OAKS, Calif., March 30, 2015 /PRNewswire/ — Amgen (NASDAQ: AMGN) will present at the Goldman Sachs Key Debates in Biosimilars conference at 9:05 a.m. ET on Thursday, April 2, . . . → Read More: Stock Update (NASDAQ:AMGN): Amgen To Present At The Goldman Sachs Key Debates In Biosimilars Conference Similar Articles: Company Update (NASDAQ:AMGN): Amgen to appeal rejection of bid to block Novartis biosimilar drug Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit Stock Update (NASDAQ:AMGN): Amgen Announces The European Medicines Agency Acceptance Of Kyprolis® (Carfilzomib) Marketing Authorization Application For The Treatment Of Relapsed Multiple Myeloma